Signup Crypto ETF Stocks News

Next-Gen Edge AI Solutions for the Real World: Autonomous Navigation for Drones, Surveillance and Robotics - Lantronix ( NASDAQ:LTRX )

IRVINE, Calif., June 17, 2025 ( GLOBE NEWSWIRE ) -- Lantronix Inc. LTRX, a global leader in compute and connectivity IoT solutions enabling Edge AI Intelligence, today announced its collaboration with Aerora, a provider of integrated NDAA-compliant propulsion, ground control and precision AI ...

Source: www.benzinga.com
June 17, 2025 | 11:00:00
Category: General

StorageVault Announces Quarterly Dividend for Q2 2025

TORONTO, June 17, 2025 ( GLOBE NEWSWIRE ) -- STORAGEVAULT CANADA INC. ( "StorageVault" or the "Corporation" ) ( SVI-TSX announced today that a quarterly dividend of $0.002961 per common share ( "Common Share" ) ‎will be payable on ‎July 15, 2025 to shareholders of record on June 30, 2025, with ...

Source: www.globenewswire.com
June 17, 2025 | 11:00:00
Category: News

Unicycive Therapeutics, Inc. Announces Reverse Stock Split

Shares Expected to Begin Trading on Split-Adjusted Basis on June 20, 2025 Shares Expected to Begin Trading on Split-Adjusted Basis on June ...

Source: www.globenewswire.com
June 17, 2025 | 11:00:00
Category: News

Whitestone REIT Acquires 5000 South Hulen in Fort Worth, Texas

High-volume asset gives Company a foothold in one of the strongest performing retail corridors in the trade area ...

Source: www.globenewswire.com
June 17, 2025 | 11:00:00
Category: News

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting - Dyne Therapeutics ( NASDAQ:DYN )

- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial support vHOT as early indicator of clinical benefit with DYNE-101 in DM1 -

Source: www.benzinga.com
June 17, 2025 | 11:00:00
Category: General

Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology - Relmada Therapeutics ( NASDAQ:RLMD )

Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC Phase 3 trial for NDV-01 expected to begin in H1 2026 CORAL GABLES, Fla., June 17, 2025 ( GLOBE NEWSWIRE ) -- Relmada Therapeutics, Inc.

Source: www.benzinga.com
June 17, 2025 | 11:00:00
Category: News

Material Update on Off-Market Takeover by Bastion Mining

TORONTO, Canada, June 17, 2025 ( GLOBE NEWSWIRE ) -- Xanadu Mines Ltd ( XAMXAM ( Xanadu or the Company ) today provides an important update in relation to the off-market takeover offer by Bastion Mining Pte. Ltd. UEN 202512367N ( Bastion ) to acquire all the fully paid, ordinary shares in Xanadu ...

Source: www.benzinga.com
June 17, 2025 | 11:00:00
Category: Mergers

Full Circle Lithium Expands Distribution Network For Its FCL-X™ Lithium-Ion Battery Fire Extinguishing Agent - Full Circle Lithium ( OTC:FCLIF )

FCL has now signed six distribution agreements to market FCL-X™ within the USA with large USA-based fire safety products distributors Due to the strong interest in FCL-X™ products, FCL has also restructured its master distribution agreement strategy in the USA into regional coverage

Source: www.benzinga.com
June 17, 2025 | 11:00:00
Category: News

Microbix Attending & Presenting at Asia Pacific POC 2025 - Microbix Biosystems ( OTC:MBXBF )

MISSISSAUGA, Ontario, June 17, 2025 ( GLOBE NEWSWIRE ) -- Microbix Biosystems Inc. ( TSX:MBX, OTCQX: MBXBF, Microbix® ) , ( TSX: MBX, OTCQX:MBXBF, Microbix® ) , Microbix® ) , a life sciences innovator, manufacturer, and exporter, announces that it is attending and presenting at the 2nd Asia ...

Source: www.benzinga.com
June 17, 2025 | 11:00:00
Category: News

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward Commercialization Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward Commercialization ...

Source: www.globenewswire.com
June 17, 2025 | 11:00:00
Category: News

© Natavest 2025 - 2026